Sandia Investment Management LP Biomea Fusion, Inc. Transaction History

Sandia Investment Management LP

  • $13.5 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$8.37 - $19.8 $20,799 - $49,203
-2,485 Reduced 40.08%
3,715 $53,000
Q3 2023

Nov 14, 2023
BUY
$13.44 - $23.02 $83,328 - $142,724
6,200 New
6,200 $85,000
Q1 2023

May 15, 2023
BUY
$6.8 - $32.35 $68,000 - $323,500
10,000 New
10,000 $310,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $189M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Sandia Investment Management LP Portfolio

Follow Sandia Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandia Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sandia Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email